Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Type of study
Language
Document Type
Year range
1.
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
Cheng, Chien-Yu; Lee, Yu-Lin; Chen, Cheng-Pin; Lin, Yi-Chun; Liu, Chun-Eng; Liao, Chia-Hung; Cheng, Shu-Hsing.
J Microbiol Immunol Infect ; 53(3): 488-492, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-31181

ABSTRACT

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.


Subject(s)
Antiviral Agents/therapeutic use , Betacoronavirus/drug effects , Coronavirus Infections/drug therapy , Coronavirus Infections/pathology , Lopinavir/therapeutic use , Pneumonia, Viral/drug therapy , Pneumonia, Viral/pathology , Ritonavir/therapeutic use , Virus Shedding/drug effects , COVID-19 , Chloroquine/therapeutic use , Drug Combinations , Female , Humans , Male , Middle Aged , Pandemics , Ribavirin/therapeutic use , SARS-CoV-2 , Taiwan
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL